India Glycols Limited — Investor Meet, 11-02-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. Financial Performance: India Glycols reported a net turnover of ₹2,905 crore for 9MFY25, representing a 22.7% increase year-over-year. The EBITDA reached ₹376 crore, up by 19.9%, yielding an EBITDA margin of 12.9%. In Q3 FY25, gross revenue was ₹2,424 crore, with a net revenue of ₹975 crore, reflecting an 8% growth compared to the previous year. EBITDA in Q3 was ₹129 crore, up 21%, while PAT surged 37% to ₹57 crore.

2. Future Outlook and Growth Drivers: Management emphasized plans for restructuring the business into three focused entities: IGL Spirits, Ennature Bio Pharma, and the Chemicals business. This segregation aims to streamline operations and unlock shareholder value. Future growth will come from expanding market share in biofuels and alcoholic beverages, particularly premium products, where the IMFL sector shows significant potential.

3. Order Book and Operational Updates: The Bio-Fuel segment has shown impressive growth, with revenues increasing 135% for 9MFY25. The Potable Spirits business also reported a 25% growth, driven by increased demand for IMFL and country liquor. The Chemicals segment faced a slight decline, attributed to operational adjustments in line with the upcoming restructuring.

4. Analyst Q&A Insights (Detailed):

- Revenue and Profitability: Analysts questioned the rationale behind the decline in the chemicals segment's revenues, which management clarified is due to reclassifications in preparation for the restructuring.

- Market Position and Competitive Landscape: The company remains optimistic about its market position, particularly focusing on leveraging its extensive ENA production for its IMFL and country liquor segments.

- Operational Challenges or Risks: Management acknowledged potential risks related to rising feedstock prices but expressed confidence in mitigating these through strategic sourcing.

- Capex and Capital Allocation: Questions arose regarding future CAPEX; management indicated that post-project assessments will guide future investments without significant increases.

- Strategic Priorities and Long-Term Vision: A commitment to enhancing brand recognition in the IMFL segment through organic growth combined with strategic partnerships was emphasized.

5. Market or Regulatory Updates: The company noted a supportive government policy for biofuels, anticipating continued demand growth. An increase in ethanol blending targets aligns with operational strategies.

6. Strategic Focus Areas: The management’s focus on premium product development, coupled with operational restructuring, signals a strong commitment towards innovation and market penetration.

7. Investor Insight: The robust financial health, combined with strategic growth plans and operational restructuring, positions India Glycols favorably for future growth. A potential 'buy' position may be aligned, considering the upward trajectory in key segments amidst planned organizational changes.